← 產業報告目錄
Cannabinoid Biosynthesis Market Size, Share & Trends Analysis Report By Type (Balanced THC and CBD, Cannabidiol Dominant, THC Dominant, and Others), By Application Type (Pain Management, Anxiety Management, Appetite Stimulation, and Nausea Management), By Region, And By Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 180報告編號 INSIGHTACE-8b44a5388a
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Cannabinoid Biosynthesis Market is positioned for steady expansion, with a projected CAGR of 14.2% from 2023 to 2031.
Cannabinoid Biosynthesis encompasses The plant contains about 480 distinct chemicals, including 66 cannabinoids. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Market momentum is supported by expanding call for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cannabinoid Biosynthesis Market Snapshot
Chapter 4. Global Cannabinoid Biosynthesis Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Type:
5.2.1. Balanced THC and CBD
5.2.2. Cannabidiol Dominant
5.2.3. THC Dominant
5.2.4. Others
Chapter 6. Market Segmentation 2: By Application Type Estimates & Trend Analysis
6.1. By Application Type & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for following By Application Type:
6.2.1. Pain Management
6.2.2. Anxiety Management
6.2.3. Appetite Stimulation
6.2.4. Nausea Management
Chapter 7. Cannabinoid Biosynthesis Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Cannabinoid Biosynthesis Market revenue (US$ Million) estimates and forecasts By Type, 2019-2031
7.1.2. North America Cannabinoid Biosynthesis Market revenue (US$ Million) estimates and forecasts By Application Type, 2019-2031
7.1.3. North America Cannabinoid Biosynthesis Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
7.1.4. Europe
7.1.5. Europe Cannabinoid Biosynthesis Market revenue (US$ Million) By Type, 2019-2031
7.1.6. Europe Cannabinoid Biosynthesis Market revenue (US$ Million) By Application Type, 2019-2031
7.1.7. Europe Cannabinoid Biosynthesis Market revenue (US$ Million) by country, 2019-2031
7.1.8. Asia Pacific
7.1.9. Asia Pacific Cannabinoid Biosynthesis Market revenue (US$ Million) By Type, 2019-2031
7.1.10. Asia Pacific Cannabinoid Biosynthesis Market revenue (US$ Million) By Application Type, 2019-2031
7.1.11. Asia Pacific Cannabinoid Biosynthesis Market revenue (US$ Million) by country, 2019-2031
7.1.12. Latin America
7.1.13. Latin America Cannabinoid Biosynthesis Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
7.1.14. Latin America Cannabinoid Biosynthesis Market revenue (US$ Million) By Application Type, (US$ Million) 2019-2031
7.1.15. Latin America Cannabinoid Biosynthesis Market revenue (US$ Million) by country, 2019-2031
7.1.16. Middle East & Africa
7.1.17. Middle East & Africa Cannabinoid Biosynthesis Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
7.1.18. Middle East & Africa Cannabinoid Biosynthesis Market revenue (US$ Million) By Application Type, (US$ Million) 2019-2031
7.1.19. Middle East & Africa Cannabinoid Biosynthesis Market revenue (US$ Million) by country, 2019-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Hyasynth Biologicals,
8.2.2. Amyris Inc,
8.2.3. Demetrix,
8.2.4. Jazz Pharmaceuticals PLC,
8.2.5. Lygos,
8.2.6. Renew Biopharma,
8.2.7. CB Therapeutics,
8.2.8. Canopy Growth Corp,
8.2.9. Zymergen Inc,
8.2.10. Cronos Group Inc.,
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們